Privately held Italian pharmaceutical firm Zambon is to purchase Munich-based drug device platform Breath Therapeutics from European venture capital firm Sofinnova Partners for €140m (US$156m). Subject to regulatory and sales milestones,…
Privately held Italian pharmaceutical firm Zambon is to purchase Munich-based drug device platform Breath Therapeutics from European venture capital firm Sofinnova Partners for €140m (US$156m). Subject to regulatory and sales milestones,…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


